Soleno Therapeutics Inc. (SLNO)
NASDAQ: SLNO
· Real-Time Price · USD
59.21
1.23 (2.12%)
At close: Oct 03, 2025, 3:59 PM
58.37
-1.42%
After-hours: Oct 03, 2025, 07:58 PM EDT
2.12% (1D)
| Bid | 56.57 |
| Market Cap | 3.15B |
| Revenue (ttm) | 32.66M |
| Net Income (ttm) | -181.08M |
| EPS (ttm) | -4.22 |
| PE Ratio (ttm) | -14.03 |
| Forward PE | 19.33 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 63.23 |
| Volume | 1,593,866 |
| Avg. Volume (20D) | 1,873,485 |
| Open | 57.79 |
| Previous Close | 57.98 |
| Day's Range | 56.87 - 60.23 |
| 52-Week Range | 41.50 - 90.32 |
| Beta | -2.75 |
| Ex-Dividend Date | n/a |
About SLNO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLNO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLNO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsSoleno Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+13.46%
Soleno Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
2 months ago
-9.23%
Soleno Therapeutics shares are trading lower after the company provided Q2 preliminary results and announced a $200 million public offering.
1 month ago · seekingalpha.com
Soleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call TranscriptSoleno Therapeutics, Inc. (NASDAQ:SLNO ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Anish Bhatnagar - Chairman, President, CEO & COO James H. MacKaness - CFO & Com...